Search

everythinglearnresearchcommunity

for

Search:↓

Yuperio combined with bisoprolol improves heart function in patients with dilated cardiomyopathy.

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.

GSK-36 downregulation with UTMD improves plaque stability in atherosclerosis treatment.

Insulin resistance increases the risk of developing type 2 diabetes and other health issues.

Fluconazole might be a new treatment for a type of diabetes that affects water balance in the body.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

The ID2 gene can help distinguish between sensitizers and irritants in skin cells.

A pancreatic tumor caused high glucagon levels and symptoms, but treatment reduced glucagon and shrank liver tumors.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Syntaxin 9 helps in transporting and signaling of the EGF receptor in skin and stomach cells.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

A special receptor in sensory nerve endings helps control how they respond to stretching.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Fesoterodine is effective and safe for elderly patients with overactive bladder.

A woman's severe skin reaction was caused by an allergy to a skin treatment.

Compound 7p shows strong potential as an anticancer agent.

Certain plant compounds can help treat diabetes.

The case emphasizes the need for careful screening in children for insulin resistance and related conditions.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

The document concludes that managing Dunnigan-Type Familial Partial Lipodystrophy involves treating associated health issues and using medications like metformin and leptin replacement.

GLP-1 receptor agonists may help or harm hair health, needing more research.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

2h-ICPR can help screen for insulin antibodies in type 2 diabetes patients.